Humasis has newly appeared among the top searched stocks.
As of 9:30 AM on the 27th, Humasis is trading at 9,850 KRW, up 3.03% from the previous day. This marks a 16.29% increase compared to November 12. Humasis is known as an in vitro diagnostic device company.
Over the past five days, individual investors have net purchased 17,230 shares, while foreigners and institutions have net purchased 14,919 shares and 7,806 shares respectively.
On November 26, Humasis was a market topic due to the news of Chairman Seo Jung-jin's proposal to promote nationwide COVID-19 testing.
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
